Akoya Biosciences, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
AKYA on Nasdaq
Location
100 Campus Drive, 6 Th Floor, Marlborough, MA

Insiders trading volume in the past year

Akoya Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Thomas A. Raffin Director $72.4M Jun 4, 2024
Matthew Winkler Director $4.41M Jun 4, 2024
Robert Shepler Director $2.23M Jun 4, 2024
Joseph Driscoll Chief Financial Officer $1.17M Dec 22, 2022
Brian McKelligon President and CEO, Director $924K -$142K -13.3% Nov 19, 2024
Niro Ramachandran Chief Business Officer $616K Nov 19, 2024
John Frederick Ek Cfo $601K Nov 19, 2024
Frederic Pla Chief Operating Officer $582K Mar 23, 2024
Pascal Bamford Chief Clinical Officer $438K Nov 19, 2024
Jennifer Kamocsay Chief Legal Officer $389K Nov 19, 2024
Myla Lai Director $89.5K Jun 4, 2024
Marilee Moy Chief People Officer $89.5K Feb 23, 2023
Ehab El-Gabry Chief Medical Officer $72.7K Feb 23, 2023
Scott Mendel Director Oct 2, 2024
Garry Nolan Director Jun 1, 2023
Thomas P. Schnettler Director Jun 4, 2024

Recent Insider Transactions by Companies or Individuals for Akoya Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.